World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
26226
World Ranking
15573
National Ranking
7848

Overview

Craig M. McDonald is affiliated with the University of California, Davis in the United States. Their research primarily focuses on muscle physiology and related disorders, with significant contributions to the understanding of neuromuscular diseases.

The main fields of study for McDonald include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these broad areas, the subfields of focus encompass:

  • Molecular Biology
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine
  • Genetics
  • Physiology

Their research topics cover diverse aspects related to muscle function and disorders:

  • Muscle Physiology and Disorders
  • Muscle activation and electromyography studies
  • Cardiomyopathy and Myosin Studies
  • Neurogenetic and Muscular Disorders Research
  • Genetic Neurodegenerative Diseases
  • Adipose Tissue and Metabolism
  • Children's Physical and Motor Development

Frequent co-authors in McDonald's publications include:

  • Eugenio Mercuri
  • Francesco Muntoni
  • Erik Henricson
  • Jean K. Mah
  • Michela Guglieri

Publications by McDonald often appear in several key venues, reflecting the focus of their work:

  • Neuromuscular Disorders
  • Journal of Neuromuscular Diseases
  • Neurology
  • Muscle & Nerve
  • Journal of Comparative Effectiveness Research

Recent papers authored or co-authored by Craig M. McDonald include:

  • "Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial", 2021, Journal of Neuromuscular Diseases
  • "Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping", 2020, JAMA Neurology
  • "Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study", 2020, Journal of Comparative Effectiveness Research
  • "Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy", 2022, JAMA
  • "Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy", 2022, JAMA Neurology

Best Publications

  • Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

    Katharine Bushby;Richard Finkel;David J. Birnkrant;Laura E. Case

  • Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

    Katharine Bushby;Richard Finkel;David J. Birnkrant;Laura E. Case

  • Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

    Craig M McDonald;R. T. Abresch;G. T. Carter;W. M. Fowler

  • Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies

    L. E. Warner;Pedro Mancias;Ian J Butler;C. M. McDonald

  • Ataluren treatment of patients with nonsense mutation dystrophinopathy

    Katharine Bushby;Richard Finkel;Brenda Wong;Richard Barohn

  • The 6-minute walk test as a new outcome measure in duchenne muscular dystrophy

    Craig M. McDonald;Erik K. Henricson;Jay J. Han;R. Ted Abresch

  • Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Craig M McDonald;Craig Campbell;Ricardo Erazo Torricelli;Richard S Finkel;Richard S Finkel

  • Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

    R. T. Moxley;S. Ashwal;S. Pandya;A. Connolly

  • Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

    Craig M McDonald;Erik K Henricson;Richard T Abresch;Tina Duong

  • The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

    Craig M McDonald;Erik K Henricson;R Ted Abresch;Julaine Florence

  • Ultrasonographic Evaluation of Diaphragmatic Motion

    Eugenio O Gerscovich;M. Cronan;John P McGahan;Kiran A Jain

  • Natural history of infantile-onset spinal muscular atrophy.

    Stephen J. Kolb;Christopher S. Coffey;Jon W. Yankey;Kristin Krosschell

  • Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

    John R Petrie;Nishi Chaturvedi;Ian Ford;Martijn C G J Brouwers

  • Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization

    Christopher Bellamy;Christopher Bellamy;C McDonald;C McDonald;Donald Salter;Donald Salter;U Chetty;U Chetty

  • THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study

    Craig M. Mcdonald;Erik K. Henricson;R. Ted Abresch;Julaine M. Florence

  • Physical activity, health impairments, and disability in neuromuscular disease

    Craig M McDonald

  • Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

    Yetrib Hathout;Edward Brody;Paula R. Clemens;Paula R. Clemens;Linda Cripe

  • Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.

    Anna Mayhew;Elena S Mazzone;Michelle Eagle;Tina Duong

  • THE COOPERATIVE INTERNATIONAL NEUROMUSCULAR RESEARCH GROUP DUCHENNE NATURAL HISTORY STUDY: GLUCOCORTICOID TREATMENT PRESERVES CLINICALLY MEANINGFUL FUNCTIONAL MILESTONES AND REDUCES RATE OF DISEASE PROGRESSION AS MEASURED BY MANUAL MUSCLE TESTING AND OTHER COMMONLY USED CLINICAL TRIAL OUTCOME MEASURES

    Erik K. Henricson;R. Ted Abresch;Avital Cnaan;Avital Cnaan;Fengming Hu

  • Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy.

    Yetrib Hathout;Edward Brody;Paula R. Clemens;Linda Cripe

Frequent Co-Authors

Eric P. Hoffman
Eric P. Hoffman Binghamton University
Richard S. Finkel
Richard S. Finkel St. Jude Children's Research Hospital
Eugenio Mercuri
Eugenio Mercuri Catholic University of the Sacred Heart
Jerry R. Mendell
Jerry R. Mendell The Ohio State University
Thomas Voit
Thomas Voit University College London
Kevin M. Flanigan
Kevin M. Flanigan The Ohio State University
Francesco Muntoni
Francesco Muntoni University College London
Avital Cnaan
Avital Cnaan Children’s National Health System
H. Lee Sweeney
H. Lee Sweeney University of Florida
Alan Pestronk
Alan Pestronk Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in careers related to medicine or healthcare but want flexible study options, there are several affordable online degree pathways to consider. For those looking to enter managerial roles within healthcare systems, exploring a bachelors in health administration can be a great starting point. This degree opens doors to entry-level leadership and administrative jobs in clinics, hospitals, and public health organizations.

Advancing further, you may look into the cheapest online mha programs, which prepare graduates for higher-level executive or policy-driven positions in healthcare. These programs are designed for working professionals seeking flexibility and affordability without compromising quality.

Nursing professionals aiming to reach the top of their field can benefit from the most affordable dnp programs. A Doctor of Nursing Practice (DNP) is an advanced degree focused on clinical practice, leadership, and evidence-based care.

Lastly, those interested in pharmaceutical sciences may consider accredited online pharmacy schools offering doctoral degrees, providing a pathway to becoming licensed pharmacists with the advantage of online coursework.

Best Scientists Citing Craig M. McDonald

Trending Scientists

Recently Published Articles